COVID-19 and its long-term impact on the cardiovascular system

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• COVID-19, caused by the SARS-CoV-2 virus, presents with diverse symptoms, including significant cardiovascular complications.
• The virus's interaction with ACE-2 and non-ACE-2 pathways contributes to myocardial damage and systemic issues like cytokine release syndrome.
• Existing cardiovascular conditions and de novo cardiac issues complicate COVID-19 patient management.

Approach:

• A comprehensive literature search was conducted on PubMed using keywords such as 'Covid 19,' 'Cardiovascular disease,' and 'Long covid.'
• The review synthesizes current data on the pathophysiology, risk factors, and clinical implications of COVID-19 on cardiovascular health.
• Analysis includes short-term (arrhythmia, myocarditis, heart failure) and long-term (diabetes, hypertension) cardiovascular sequelae.

Key Points:

• SARS-CoV-2 infection can lead to acute respiratory distress syndrome, multiorgan failure, and direct myocardial damage.
• Cardiovascular medications may interact with COVID-19 treatments, necessitating careful pharmacologic consideration.
• Long-term effects of COVID-19 include increased risk for conditions like diabetes and hypertension.

Conclusions:

• Effective management strategies for cardiology healthcare are essential, particularly for patients with Long-COVID.
• Future research should explore the application of AI and automated data analysis to understand COVID-19's cardiovascular sequelae.
• Proactive planning and advanced management are crucial for addressing the cardiovascular burden of the COVID-19 pandemic.